Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$809M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$396M |
| 3 |
Zoetis
ZTS
|
+$278M |
| 4 |
iShares Core MSCI Europe ETF
IEUR
|
+$268M |
| 5 |
Microsoft
MSFT
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$433M |
| 2 |
Medtronic
MDT
|
+$371M |
| 3 |
Bank of America
BAC
|
+$124M |
| 4 |
Corning
GLW
|
+$123M |
| 5 |
Vanguard FTSE Pacific ETF
VPL
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.68% |
| 2 | Financials | 8.02% |
| 3 | Industrials | 7.08% |
| 4 | Healthcare | 6.16% |
| 5 | Consumer Discretionary | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5151
Caribou Biosciences
CRBU
$164M
| $31.1K | ﹤0.01% |
+16,373
| New | +$28.1K |
|
5152
TELA Bio
TELA
$38.9M
| $30.8K | ﹤0.01% |
49,700
+19,500
| +65% | +$16.9K |
|
|
RIME
5153
Algorhythm Holdings
RIME
$6.57M
| $30.5K | ﹤0.01% |
+28,000
| New | +$37.9K |
|
5154
Black Diamond Therapeutics
BDTX
$112M
| $30.1K | ﹤0.01% |
14,115
+647
| +5% | +$1.54K |
|
5155
Arbe Robotics
ARBE
$94.2M
| $30K | ﹤0.01% |
49,184
+24,534
| +100% | +$25.5K |
|
5156
CALL
Grab
GRAB
$14.9B
| $30K | ﹤0.01% |
10,000
| – | – |
|
5157
PUT
Invesco Aerospace & Defense ETF
PPA
$8.7B
| $30K | ﹤0.01% |
+200
| New | +$35K |
|
5158
Humacyte
HUMA
$194M
| $29.3K | ﹤0.01% |
48,329
-3,000
| -6% | -$3.12K |
|
5159
Martin Midstream Partners
MMLP
$95.9M
| $29.2K | ﹤0.01% |
10,594
-4,050
| -28% | -$11.3K |
|
5160
PUT
Alibaba
BABA
$308B
| $29K | ﹤0.01% |
+200
| New | +$30.1K |
|
|
FLNA
5161
Filana Therapeutics
FLNA
$48.1M
| $28.9K | ﹤0.01% |
17,104
-13,360
| -44% | -$27.5K |
|
5162
Inovio Pharmaceuticals
INO
$69M
| $28.8K | ﹤0.01% |
16,543
-145
| -0.9% | -$239 |
|
|
DVLT
5163
Datavault AI
DVLT
$263M
| $28.8K | ﹤0.01% |
46,539
-30,594
| -40% | -$23.2K |
|
|
ONCY
5164
Oncolytics Biotech
ONCY
$95.8M
| $28.6K | ﹤0.01% |
33,751
+383
| +1% | +$381 |
|
5165
CALL
First Majestic Silver
AG
$9.07B
| $28K | ﹤0.01% |
+1,600
| New | +$36.9K |
|
5166
CALL
SPDR Gold Trust
GLD
$141B
| $28K | ﹤0.01% |
100
| – | – |
|
5167
Dare Bioscience
DARE
$21M
| $27.9K | ﹤0.01% |
15,334
| – | – |
|
5168
CarParts.com
PRTS
$54.7M
| $27.2K | ﹤0.01% |
3,463
| – | – |
|
5169
BRC Inc
BRCC
$250M
| $27.2K | ﹤0.01% |
35,005
+975
| +3% | +$821 |
|
|
CIK
5170
Credit Suisse Asset Management Income Fund
CIK
$134M
| $27.1K | ﹤0.01% |
10,597
| – | – |
|
5171
Avalon Holdings
AWX
$10.1M
| $26.6K | ﹤0.01% |
+10,260
| New | +$27.1K |
|
|
GXAI
5172
Gaxos.ai
GXAI
$9.13M
| $25.4K | ﹤0.01% |
21,000
| – | – |
|
5173
Bullfrog AI
BFRG
$10.9M
| $25.2K | ﹤0.01% |
15,000
| – | – |
|
5174
Quest Resource Holding
QRHC
$31.6M
| $25K | ﹤0.01% |
+21,000
| New | +$36.6K |
|
5175
American Resources Corp
AREC
$293M
| $24.9K | ﹤0.01% |
+10,289
| New | +$32.7K |
|
Similar funds
Raymond James Financial's Q1 2026 Portfolio in Review
As of Q1 2026, Raymond James Financial held 5,490 positions worth $324B, up 0.94% from $321B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Raymond James Financial's Q1 2026 filing shows 349 new, 2,830 increased, 1,948 reduced and 210 closed positions. Its largest new stake was Lazard International Dynamic Equity ETF: 663,484 shares worth $21.1M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
- Raymond James Financial's largest Q1 2026 buy was Lazard International Dynamic Equity ETF: 663,484 shares worth $21.1M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $809M increase.
- Raymond James Financial's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $433M.
- Raymond James Financial fully exited New Gold Inc in Q1 2026, selling an estimated $19M.
- Raymond James Financial's ten largest holdings make up 21% of its $324B portfolio in Q1 2026.
- Raymond James Financial opened 349 new positions and closed 210 in Q1 2026.
- Raymond James Financial's portfolio value rose 0.94% quarter-over-quarter to $324B.
Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.